We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EGA Identifies Patent Obstacles to Generics in Europe
EGA Identifies Patent Obstacles to Generics in Europe
June 10, 2008
Failures in the patent-granting system, the use of weak follow-on patents and the unpredictability of litigation are hindering the entry of generic medicines in the European market, according to a report by the European Generic medicines Association (EGA).